WallStreetZenWallStreetZen

NASDAQ: STOK
Stoke Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

STOK past revenue growth

How has STOK's revenue growth performed historically?
Company
-29.22%
Industry
148.4%
Market
16.96%
STOK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
STOK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

STOK earnings and revenue history

Current Revenue
$8.8M
Current Earnings
-$104.7M
Current Profit Margin
-1,192.5%

STOK Return on Equity

Current Company
-56.9%
Current Industry
-63.5%
Current Market
188%
STOK's Return on Equity (-56.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when STOK announces earnings.

STOK Return on Assets

Current Company
-41.6%
Current Industry
2.9%
STOK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

STOK Return on Capital Employed

Current Company
-58.02%
Current Industry
19.5%
STOK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

STOK vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
STOK$8.78M-$109.88M-$104.70M-29.22%N/A
VALN$167.08M-$81.85M-$110.25M+4.76%N/A
ORIC$0.00-$99.67M-$100.70MN/AN/A
OABI$34.16M-$44.87M-$50.62M+16.86%N/A
PHAT$682.00k-$159.05M-$201.59MN/AN/A
View Top Biotech Stocks

STOK earnings dates

Next earnings date
May 2, 2024

Stoke Therapeutics Earnings & Revenue FAQ

What were STOK's earnings last quarter?

On Invalid Date, Stoke Therapeutics (NASDAQ: STOK) reported Q4 2023 earnings per share (EPS) of -$0.60, up 7.69% year over year. Total Stoke Therapeutics earnings for the quarter were -$26.96 million. In the same quarter last year, Stoke Therapeutics's earnings per share (EPS) was -$0.65.

If you're new to stock investing, here's how to buy Stoke Therapeutics stock.

What was STOK's earnings growth in the past year?

As of Q2 2024, Stoke Therapeutics's earnings has grown year over year. Stoke Therapeutics's earnings in the past year totalled -$104.70 million.

What is STOK's earnings date?

Stoke Therapeutics's earnings date is Invalid Date. Add STOK to your watchlist to be reminded of STOK's next earnings announcement.

What was STOK's revenue last quarter?

On Invalid Date, Stoke Therapeutics (NASDAQ: STOK) reported Q4 2023 revenue of $2.80 million up 14.26% year over year. In the same quarter last year, Stoke Therapeutics's revenue was $3.27 million.

What was STOK's revenue growth in the past year?

As of Q2 2024, Stoke Therapeutics's revenue has grown -29.22% year over year. This is 177.63 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Stoke Therapeutics's revenue in the past year totalled $8.78 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.